Brought to you by 
PPD licenses rights to Eli Lilly's genitourinary compounds
22 Dec 2003
Executive Summary
Pharmaceutical Product Development has licensed worldwide rights to a number of Eli Lilly's genitourinary compounds outside of Lilly's core research focus, including those that target bladder and sexual dysfunction.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Terminated
Deal Type
-
Alliance
- Joint Venture
- R&D and Marketing (Licensing)
- Reverse Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com